ts_code,end_date,bz_item,bz_code,bz_sales,bz_profit,bz_cost,curr_type
301230.SZ,20250630,工艺研究与开发,P,28584452.29,1813919.53,26770532.76,CNY
301230.SZ,20250630,医药研发服务,P,185783780.72,66157553.5,119626227.22,CNY
301230.SZ,20250630,其他业务,P,14908460.34,14618071.48,290388.86,CNY
301230.SZ,20250630,工艺研究与开发,P,28584452.29,1813919.53,26770532.76,CNY
301230.SZ,20250630,商业化生产,P,123461379.48,15933467.72,107527911.76,CNY
301230.SZ,20250630,商业化生产,P,123461379.48,15933467.72,107527911.76,CNY
301230.SZ,20250630,医药研发服务,P,185783780.72,66157553.5,119626227.22,CNY
301230.SZ,20250630,其他业务,P,14908460.34,14618071.48,290388.86,CNY
301230.SZ,20241231,中国大陆,D,122173272.44,648956.33,121524316.11,CNY
301230.SZ,20241231,医药研发服务,P,316571851.12,103770808.5,212801042.62,CNY
301230.SZ,20241231,国外,D,407773609.57,114766895.08,293006714.49,CNY
301230.SZ,20241231,渠道贸易,455006000,10396290.95,5107808.82,5288482.13,CNY
301230.SZ,20241231,直销,455006000,534074971.09,124826367.37,409248603.72,CNY
301230.SZ,20241231,工艺研究与开发,P,48160997.27,-992906.68,49153903.95,CNY
301230.SZ,20241231,商业化生产,P,165214033.62,12637949.59,152576084.03,CNY
301230.SZ,20241231,其他业务,P,14524380.03,14518324.78,6055.25,CNY
301230.SZ,20241231,其他业务(地区),D,14524380.03,14518324.78,6055.25,CNY
301230.SZ,20240630,医药研发服务,P,158235327.69,52487822.57,105747505.12,CNY
301230.SZ,20240630,其他业务,P,6366115.92,,,CNY
301230.SZ,20240630,工艺研究与开发,P,21965693.22,1598236.98,20367456.24,CNY
301230.SZ,20240630,商业化生产,P,79196377.63,2744818.8,76451558.83,CNY
301230.SZ,20231231,其他业务,P,9238781.65,9238781.65,,CNY
301230.SZ,20231231,国外,D,341918196.2,,,CNY
301230.SZ,20231231,中国大陆,D,147798878.69,,,CNY
301230.SZ,20231231,其他收入-产品,P,9238781.65,9238781.69,-0.04,CNY
301230.SZ,20231231,商业化生产,P,109401023.32,17314804.75,92086218.57,CNY
301230.SZ,20231231,工艺研究与开发,P,77868176.89,23504462.95,54363713.94,CNY
301230.SZ,20231231,医药研发服务,P,293209093.03,101144398.13,192064694.9,CNY
301230.SZ,20231231,其他业务收入,P,9238781.65,9238781.69,-0.04,CNY
301230.SZ,20230630,其他业务,P,8538612.37,8538612.37,,CNY
301230.SZ,20230630,医药研发服务,P,137895540.55,48977738.8,88917801.75,CNY
301230.SZ,20230630,工艺研究与开发,P,41057123.95,17598733.52,23458390.43,CNY
301230.SZ,20230630,药学研究服务,P,4202266.79,1242705.6,2959561.19,CNY
301230.SZ,20230630,商业化生产,P,45961516.31,11960328.34,34001187.97,CNY
301230.SZ,20221231,医药研发服务,P,274726371.37,104712278.12,170014093.25,CNY
301230.SZ,20221231,商业化生产,P,117088309.67,29609363.69,87478945.98,CNY
301230.SZ,20221231,科学研究和技术服务业,I,472122201.48,169821347.07,302300854.41,CNY
301230.SZ,20221231,国外,D,338451917.78,132421947.84,206029969.94,CNY
301230.SZ,20221231,其他业务(地区),D,6761582.54,6761201.89,380.65,CNY
301230.SZ,20221231,中国大陆,D,133670283.7,37399399.23,96270884.47,CNY
301230.SZ,20221231,工艺研究与开发,P,80307520.44,35499705.26,44807815.18,CNY
301230.SZ,20221231,其他业务,P,6761582.54,6761201.89,380.65,CNY
301230.SZ,20211231,美国,D,226543356.35,,,CNY
301230.SZ,20211231,印度,D,29142387.17,,,CNY
301230.SZ,20211231,其他主营业务,D,58101242.27,,,CNY
301230.SZ,20211231,医药研发服务,P,234891700.0,96606000.0,138285700.0,CNY
301230.SZ,20211231,工艺研究与开发,P,92827100.0,40785800.0,52041300.0,CNY
301230.SZ,20211231,替格瑞洛系列中间体,P,108838600.0,,,CNY
301230.SZ,20211231,维帕他韦系列中间体,P,16500.0,,,CNY
301230.SZ,20211231,其他商业化生产产品,P,9161400.0,,,CNY
301230.SZ,20211231,华东,D,100440800.0,,,CNY
301230.SZ,20211231,华北,D,23720400.0,,,CNY
301230.SZ,20211231,东北,D,8000.0,,,CNY
301230.SZ,20211231,华南,D,3682100.0,,,CNY
301230.SZ,20211231,帕拉米韦系列中间体,P,703800.0,,,CNY
301230.SZ,20211231,西北,D,464000.0,,,CNY
301230.SZ,20211231,西南,D,4336800.0,,,CNY
301230.SZ,20211231,其他业务,P,1774554.22,1763897.55,10656.67,CNY
301230.SZ,20211231,其他业务(地区),D,1774596.47,,,CNY
301230.SZ,20210630,替格瑞洛系列中间体,P,59277800.0,,,CNY
301230.SZ,20210630,其他商业化生产产品,P,6086700.0,,,CNY
301230.SZ,20210630,医药研发服务,P,104221200.0,42755300.0,61465900.0,CNY
301230.SZ,20210630,工艺研究与开发,P,18526100.0,8831500.0,9694600.0,CNY
301230.SZ,20210630,华东,D,46130600.0,,,CNY
301230.SZ,20210630,华北,D,6315700.0,,,CNY
301230.SZ,20210630,华南,D,3451800.0,,,CNY
301230.SZ,20210630,西南,D,9100.0,,,CNY
301230.SZ,20210630,东北,D,8200.0,,,CNY
301230.SZ,20210630,美国,D,84091847.1,,,CNY
301230.SZ,20210630,印度,D,14315140.01,,,CNY
301230.SZ,20210630,其他主营业务,D,34036015.43,,,CNY
301230.SZ,20210630,西北,D,477200.0,,,CNY
301230.SZ,20210630,帕拉米韦系列中间体,P,723900.0,,,CNY
301230.SZ,20210630,其他业务(地区),D,598500.88,,,CNY
301230.SZ,20210630,其他业务,P,598478.77,587846.92,10631.85,CNY
301230.SZ,20201231,美国,D,111263585.47,,,CNY
301230.SZ,20201231,印度,D,60389391.51,,,CNY
301230.SZ,20201231,其他主营业务,D,47067054.09,,,CNY
301230.SZ,20201231,医药研发服务,P,132393900.0,58052700.0,74341200.0,CNY
301230.SZ,20201231,工艺研究与开发,P,32242700.0,14613300.0,17629400.0,CNY
301230.SZ,20201231,替格瑞洛系列中间体,P,99243600.0,,,CNY
301230.SZ,20201231,帕拉米韦系列中间体,P,4735100.0,,,CNY
301230.SZ,20201231,其他商业化生产产品,P,10309700.0,,,CNY
301230.SZ,20201231,华东,D,45374000.0,,,CNY
301230.SZ,20201231,华北,D,11017800.0,,,CNY
301230.SZ,20201231,其他业务(地区),D,4488036.98,,,CNY
301230.SZ,20201231,华中,D,23800.0,,,CNY
301230.SZ,20201231,华南,D,2121500.0,,,CNY
301230.SZ,20201231,维帕他韦系列中间体,P,-423600.0,,,CNY
301230.SZ,20201231,西南,D,1244400.0,,,CNY
301230.SZ,20201231,其他业务,P,4488083.86,4437149.33,50934.53,CNY
301230.SZ,20200930,医药研发服务,P,93133500.0,42187300.0,50946200.0,CNY
301230.SZ,20200930,工艺研究与开发,P,16255400.0,8231500.0,8023900.0,CNY
301230.SZ,20200930,其他业务(地区),D,3593726.37,,,CNY
301230.SZ,20200930,中国大陆,D,38122771.43,,,CNY
301230.SZ,20200930,美国,D,75498974.19,,,CNY
301230.SZ,20200930,印度,D,54664664.53,,,CNY
301230.SZ,20200930,其他主营业务,D,28779140.29,,,CNY
301230.SZ,20200930,替格瑞洛系列中间体,P,79322600.0,,,CNY
301230.SZ,20200930,帕拉米韦系列中间体,P,4659900.0,,,CNY
301230.SZ,20200930,其他商业化生产产品,P,4122900.0,,,CNY
301230.SZ,20200930,维帕他韦系列中间体,P,-428700.0,,,CNY
301230.SZ,20200930,其他业务,P,3593676.81,3548578.82,45097.99,CNY
301230.SZ,20191231,美国,D,93170132.21,,,CNY
301230.SZ,20191231,印度,D,62971335.47,,,CNY
301230.SZ,20191231,其他主营业务,D,40957098.58,,,CNY
301230.SZ,20191231,医药研发服务,P,92185200.0,41503900.0,50681300.0,CNY
301230.SZ,20191231,工艺研究与开发,P,34354700.0,18545400.0,15809300.0,CNY
301230.SZ,20191231,替格瑞洛系列中间体,P,94720800.0,,,CNY
301230.SZ,20191231,维帕他韦系列中间体,P,15321800.0,,,CNY
301230.SZ,20191231,其他商业化生产产品,P,3995500.0,,,CNY
301230.SZ,20191231,华东,D,16010300.0,,,CNY
301230.SZ,20191231,华北,D,28465900.0,,,CNY
301230.SZ,20191231,其他业务(地区),D,2697597.37,,,CNY
301230.SZ,20191231,帕拉米韦系列中间体,P,1924100.0,,,CNY
301230.SZ,20191231,西北,D,195400.0,,,CNY
301230.SZ,20191231,西南,D,731900.0,,,CNY
301230.SZ,20191231,其他业务,P,2697639.5,1603720.4,1093919.1,CNY
301230.SZ,20190630,医药研发服务,P,57268458.99,34077489.63,23190969.36,CNY
301230.SZ,20190630,医药中间体等销售,P,46462621.14,15942814.34,30519806.8,CNY
301230.SZ,20181231,维帕他韦系列中间体,P,4520100.0,,,CNY
301230.SZ,20181231,帕拉米韦系列中间体,P,1363900.0,,,CNY
301230.SZ,20181231,工艺研究与开发,P,24912200.0,13830300.0,11081900.0,CNY
301230.SZ,20181231,替格瑞洛系列中间体,P,30625400.0,,,CNY
301230.SZ,20181231,其他商业化生产产品,P,4790400.0,,,CNY
301230.SZ,20181231,其他业务,P,2130106.56,731240.16,1398866.4,CNY
301230.SZ,20181231,其他业务(地区),D,2130066.11,,,CNY
301230.SZ,20181231,美国,D,75019079.31,,,CNY
301230.SZ,20181231,印度,D,16124894.0,,,CNY
301230.SZ,20181231,其他主营业务,D,7581255.39,,,CNY
301230.SZ,20181231,华东,D,20273500.0,,,CNY
301230.SZ,20181231,华北,D,3033300.0,,,CNY
301230.SZ,20181231,华中,D,4300.0,,,CNY
301230.SZ,20181231,东北,D,21100.0,,,CNY
301230.SZ,20181231,华南,D,531000.0,,,CNY
301230.SZ,20181231,医药研发服务,P,57472100.0,23547400.0,33924700.0,CNY
301230.SZ,20181231,西北,D,38100.0,,,CNY
301230.SZ,20181231,西南,D,1057600.0,,,CNY
301230.SZ,20180630,医药中间体等销售,P,23554417.55,6793479.28,16760938.27,CNY
301230.SZ,20180630,医药研发服务,P,35836207.46,18662438.12,17173769.34,CNY
301230.SZ,20171231,医药研发服务,P,57923800.0,27512000.0,30411800.0,CNY
301230.SZ,20171231,工艺研究与开发,P,24335500.0,15320500.0,9015000.0,CNY
301230.SZ,20171231,替格瑞洛系列中间体,P,19446500.0,,,CNY
301230.SZ,20171231,维帕他韦系列中间体,P,20169500.0,,,CNY
301230.SZ,20171231,其他商业化生产产品,P,7804200.0,,,CNY
301230.SZ,20171231,中国大陆,D,22828142.06,,,CNY
301230.SZ,20171231,美国,D,77378154.25,,,CNY
301230.SZ,20171231,印度,D,27090540.25,,,CNY
301230.SZ,20171231,其他主营业务,D,2846511.11,,,CNY
301230.SZ,20171231,帕拉米韦系列中间体,P,463900.0,,,CNY
